Bayer will test the new drug with Israeli 3D-printed heart tissue

JERUSALEM, June 28 (Xinhua Chen Wenxian Shangxuan) Israel's Tel Aviv University said in a statement on the 28th that the university has signed a cooperation agreement with Bayer Pharmaceuticals of Germany, the latter will test the university's 3D-printed human heart tissue on the new drug, the future also plans to test the efficacy and toxicity of the new drug on the entire heart printed in 3D.
said in a statement that Tel Aviv University researchers successfully 3D-printed the world's first complete "heart" with cells, blood vessels, a cardiac and adulations in April last year, an innovative technology that also has great potential in the medical field of drug screening.
drug candidates go through multiple screening stages before they go on the market, first on laboratory-cultured human tissue and then on experimental animals before they can be approved for human clinical trials. Testing drug candidates with 3D-printed human tissue can make the drug screening process faster, cheaper and more efficient, the statement said.
DeVere, who heads the university's Tal de Ville Tissue Engineering and Regenerative Medicine Laboratory, said in a statement that 3D-printed human tissue is closer to real heart tissue.
the lab will also design and manufacture entire human hearts with all the different chambers, valves, arteries and veins for better drug screening, Mr. DeVere said.